A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease

CNS Drugs

Volumn 28, Issue 12, 2014, Pages 1185-1189

  Rosenbloom, Michael H ^a,b   Barclay, Terry R ^a,b   Pyle, Maria ^a,b   Owens, Brian L ^a,b   Cagan, Amanda B ^a,b   Anderson, Christopher P ^b   Frey, William H ^a,b   Hanson, Leah R ^a,b  

^a REGIONS HOSPITAL   (United States)

^b HEALTHPARTNERS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; GLUCOSE; INSULIN; INSULIN GLULISINE; PIG INSULIN; PLACEBO; SHORT ACTING INSULIN; GLUCOSE BLOOD LEVEL; NOOTROPIC AGENT; PHARMACOLOGICAL BIOMARKER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; INSULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; BLOOD; COGNITION; DRUG EFFECTS; GENETICS; INTRANASAL DRUG ADMINISTRATION; MEMORY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BIOMARKERS, PHARMACOLOGICAL; BLOOD GLUCOSE; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HETEROZYGOTE; HUMANS; INSULIN; INSULIN, SHORT-ACTING; MALE; MEMORY; NOOTROPIC AGENTS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84922073485     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-014-0214-y     Document Type: Article

References (16)

1. Benedict C, Hallschmid M, Hatke A, et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology. 2004;29(10):1326-34.
2. Freiherr J, Hallschmid M, Frey WH 2nd, et al. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence. CNS Drugs. 2013;27(7):505-14.
3. Steen E, Terry BM, Rivera EJ, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis. 2005;7(1):63-80.
4. Reger MA, Watson GS, Frey WH 2nd, et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging. 2006;27(3):451-8.
5. Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29-38.
6. Schioth HB, Frey WH, Brooks SJ, Benedict C. Insulin to treat Alzheimer's disease: just follow your nose? Expert Rev Clin Pharmacol. 2012;5(1):17-20.
7. Benedict C, Hallschmid M, Schultes B, Born J, Kern W. Intranasal insulin to improve memory function in humans. Neuroendocrinology. 2007;86(2):136-42.
8. Benedict C, Hallschmid M, Schmitz K, et al. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology. 2007;32(1):239-43.
9. Jafek BW, Linschoten MR, Murrow BW. Anosmia after intranasal zinc gluconate use. Am J Rhinol. 2004;18(3):137-41.
10. Davidson TM, Smith WM. The Bradford Hill criteria and zinc-induced anosmia: a causality analysis. Arch Otolaryngol Head Neck Surg. 2010;136(7):673-6.
11. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association Workgroups on Diagnostic Guidelines for Alzheimer's Disease. Alzheimers Dement. 2011;7(3):263-9.
12. Dulay MF, Gesteland RC, Shear PK, Ritchey PN, Frank RA. Assessment of the influence of cognition and cognitive processing speed on three tests of olfaction. J Clin Exp Neuropsychol. 2008;30(3):327-37.
13. Frank RA, Gesteland RC, Bailie J, Rybalsky K, Seiden A, Dulay MF. Characterization of the Sniff Magnitude Test. Arch Otolaryngol Head Neck Surg. 2006;132(5):532-6.
14. Reger MA, Watson GS, Green PS, et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis. 2008;13(3):323-31.
15. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349-56.
16. Valla J, Yaari R, Wolf AB, et al. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis. 2010;22(1):307-13.